UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029494
Receipt number R000021075
Scientific Title Acquired immune response to cytomegalovirus in corneal endotheliitis
Date of disclosure of the study information 2017/10/11
Last modified on 2018/10/12 09:55:11

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Acquired immune response to cytomegalovirus in corneal endotheliitis

Acronym

Acquired immune response to CMV in corneal endotheliitis

Scientific Title

Acquired immune response to cytomegalovirus in corneal endotheliitis

Scientific Title:Acronym

Acquired immune response to CMV in corneal endotheliitis

Region

Japan


Condition

Condition

corneal endotheliitis

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

the cause of cytomegalovirus corneal endotheliitis is unknown. since it develop in non immunocompromised patient, immune mechanism involved in CMV seems to be in a special state. what is more, CMV T cell epitope is shown to be responsible for idiopathic corneal endotheliitis. we try to illustrate the mechanism from perspective of activation of epitope-specific acquired immunity.

Basic objectives2

Others

Basic objectives -Others

pathology

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

antigen-specific CD8+ T cell ratio and cytokine profile.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

corneal endotheliitis patient and healthy person as control.

Key exclusion criteria

patient did not give written informed consent.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name MIYAZAKI Dai

Organization

Tottori university

Division name

Division of Ophthalmology and Visual Science

Zip code


Address

36-1 Nishi-cho, Yonago, Tottori

TEL

0859-38-6617

Email

dm@med.tottori-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name MIYAZAKI Dai

Organization

Tottori university

Division name

Division of Ophthalmology and Visual Science

Zip code


Address

36-1 Nishi-cho, Yonago, Tottori

TEL

0859-38-6617

Homepage URL


Email

dm@med.tottori-u.ac.jp


Sponsor or person

Institute

Tottori university Division of Ophthalmology and Visual Science

Institute

Department

Personal name



Funding Source

Organization

Tottori university Division of Ophthalmology and Visual Science

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 10 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 07 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observe the difference in immune response to cytomegalovirus in patients with corneal endothelitis and healthy subjects.


Management information

Registered date

2017 Year 10 Month 10 Day

Last modified on

2018 Year 10 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021075


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name